Telisotuzumab vedotin is an antibody-drug conjugate targeting c-MET, comprised of the anti-c-MET monoclonal antibody Telisotuzumab and the cytotoxic agent Monomethyl Auristatin E. This compound demonstrates antitumor efficacy in vivo while maintaining acceptable toxicity levels. It is primarily utilized in research focusing on non-small cell lung cancer (NSCLC), making it a valuable tool for investigating therapeutic approaches in this area.
Telisotuzumab vedotin is an antibody-drug conjugate targeting c-MET, comprised of the anti-c-MET monoclonal antibody Telisotuzumab and the cytotoxic agent Monomethyl Auristatin E. This compound demonstrates antitumor efficacy in vivo while maintaining acceptable toxicity levels. It is primarily utilized in research focusing on non-small cell lung cancer (NSCLC), making it a valuable tool for investigating therapeutic approaches in this area.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
